Provided by Tiger Fintech (Singapore) Pte. Ltd.

HANSOH PHARMA

19.420
+0.4002.10%
Volume:6.74M
Turnover:130.53M
Market Cap:115.27B
PE:32.75
High:19.560
Open:19.420
Low:19.180
Close:19.020
Loading ...

Hansoh Pharmaceutical - Hs-20093 Received FDA Breakthrough Therapy Designation in Late-Line Relapsed or Refractory Osteosarcoma

THOMSON REUTERS
·
07 Jan

China Healthcare Sector to Get Policy Boost in 1Q -- Market Talk

Dow Jones
·
07 Jan

Hansoh Pharmaceutical Group Company Limited (HKG:3692) Investors Are Less Pessimistic Than Expected

Simply Wall St.
·
28 Dec 2024

FACTBOX-Weight-loss drug developers line up to tap market worth $150 billion

Reuters
·
20 Dec 2024

Hansoh Pharmaceutical Units Sign Up to $2 Billion Licensing Deal for Weight Loss Drug Candidate

MT Newswires Live
·
20 Dec 2024

BUZZ-Shares of some obesity drug developers fall after Merck signs $2 bln deal to develop oral obesity drug

Reuters
·
18 Dec 2024

BRIEF-Hansoh Pharmaceutical Says Units Entered License Agreement With Unit Of Merck Sharp + Dohme Llc

Reuters
·
18 Dec 2024

Merck, Hansoh Pharma in Obesity Pill License Potentially Worth More Than $2 Billion

Dow Jones
·
18 Dec 2024

BUZZ-Merck rises on license deal with China's Hansoh Pharma

Reuters
·
18 Dec 2024

Merck Shares up 1.1% Premarket After Co Signs up to $2 Bln Obesity Drug Deal With Hansoh

THOMSON REUTERS
·
18 Dec 2024

Merck signs up to $2 bln obesity drug deal with Chinese biotech Hansoh

Reuters
·
18 Dec 2024

BRIEF-Merck Enters Into Exclusive Global License Agreement With Hansoh Pharma For Investigational Oral GLP-1 Receptor Agonist

Reuters
·
18 Dec 2024

BRIEF-Merck In Pact For Chinese Obesity Drug In Nearly $2 Billion Deal - Bloomberg News

Reuters
·
18 Dec 2024

Merck Will Gain Exclusive Global License to Develop, Manufacture & Commercialize Chinese Drugmaker Hansoh Pharmaceutical Group's Hs-10535 -Bloomberg News

THOMSON REUTERS
·
18 Dec 2024

Hansoh Pharmaceutical - Licensors to Receive Upfront Payment of US$112 Mln and Eligible to Receive up to US$1.9 Bln in Milestone Payments

THOMSON REUTERS
·
18 Dec 2024

Hansoh Pharmaceutical - Units Entered Exclusive Global License Agreement With Unit of Merck Sharp + Dohme Llc

THOMSON REUTERS
·
18 Dec 2024